R-CODOX-M Regimen

Preferred Label : R-CODOX-M Regimen;

NCIt synonyms : Cyclophosphamide/Doxorubicin/Methotrexate/Rituximab/Vincristine; Cyclophosphamide/Doxorubicin/Methotrexate/Rituximab/Vincristine Regimen; Rituximab/Cyclophosphamide/Oncovin/Doxorubicin/Methotrexate; Rituxan/Cytoxan/Oncovin/Adriamycin/Methotrexate; Rituximab/Cyclophosphamide/Oncovin/Doxorubicin/Methotrexate Regimen; Rituximab-Cyclophosphamide-Vincristine-Doxorubicin-Methotrexate;

NCIt related terms : R-CODOX-M; R-CODOX-M (rituximab-rixa); R-CODOX-M (rituximab-pvvr); R-CODOX-M (rituximab-blit); R-CODOX-M (rituximab-abbs); R-CODOX-M (rituximab-arrx); R-CODOX-M (rituximab-rixi); R-CODOX-M (rituximab-rite);

NCIt definition : A regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (CODOX-M) and rituximab that can be used in the treatment of non-Hodgkin lymphoma (NHL), including Burkitt lymphoma.;

NCI Metathesaurus CUI : CL969499;

Codes from synonyms : 128358; 127887; 128515; 128672; 10639; 127730; 128044; 128201;

Details

Origin ID

C160567;

UMLS CUI

C5205362;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Methotrexate Sodium [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients